JP2005314380A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005314380A5 JP2005314380A5 JP2005088634A JP2005088634A JP2005314380A5 JP 2005314380 A5 JP2005314380 A5 JP 2005314380A5 JP 2005088634 A JP2005088634 A JP 2005088634A JP 2005088634 A JP2005088634 A JP 2005088634A JP 2005314380 A5 JP2005314380 A5 JP 2005314380A5
- Authority
- JP
- Japan
- Prior art keywords
- insulin resistance
- agent
- improving agent
- insulin
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005088634A JP2005314380A (ja) | 2004-03-29 | 2005-03-25 | インスリン抵抗性改善剤を含有する糖尿病治療剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004094598 | 2004-03-29 | ||
| JP2005088634A JP2005314380A (ja) | 2004-03-29 | 2005-03-25 | インスリン抵抗性改善剤を含有する糖尿病治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005314380A JP2005314380A (ja) | 2005-11-10 |
| JP2005314380A5 true JP2005314380A5 (https=) | 2008-04-24 |
Family
ID=35442165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005088634A Withdrawn JP2005314380A (ja) | 2004-03-29 | 2005-03-25 | インスリン抵抗性改善剤を含有する糖尿病治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005314380A (https=) |
-
2005
- 2005-03-25 JP JP2005088634A patent/JP2005314380A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2519660C2 (ru) | Режим дозировки селективного агониста рецептора s1p1 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2012520866A5 (https=) | ||
| JP2014528474A5 (https=) | ||
| JP2018507243A5 (https=) | ||
| JP2010540519A5 (https=) | ||
| JP2016138142A (ja) | 大うつ病を有する患者において減量療法を提供する方法 | |
| JP2020529440A5 (https=) | ||
| Park et al. | Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system | |
| JP2018509419A5 (https=) | ||
| JP2020536121A5 (https=) | ||
| JP2025072496A (ja) | ジスキネジア治療薬 | |
| CN101437530A (zh) | 一种烟叶提取物及其在依赖治疗中的应用 | |
| JP2009506043A5 (https=) | ||
| BR112019026029A2 (pt) | Formulações farmacêuticas orais de remogliflozina | |
| JP2012502105A5 (https=) | ||
| JP2005314380A5 (https=) | ||
| JP2006508118A5 (https=) | ||
| JP6454436B1 (ja) | ペマフィブラートを含有する医薬 | |
| JP2001039976A5 (https=) | ||
| WO2016001185A1 (en) | Dosage regimen for the treatment of diabetes | |
| KR20200136008A (ko) | 신경퇴행성 장애의 치료를 위한 약제학적 조성물의 연속 투여 | |
| JP2009501707A5 (https=) | ||
| JP6420923B1 (ja) | 医薬 | |
| JP2016503406A5 (https=) |